New chairman at Urigen Pharmaceuticals
This article was originally published in Scrip
Executive Summary
Dr Edward Teitel has been elected chairman of Urigen Pharmaceuticals (US), a speciality company developing treatments for urological disorders and pain. Dr Teitel currently serves as president and chief executive officer of ThromboVision.